phosphocyclocreatine has been researched along with Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hamlin, HA; Kaddurah-Daouk, R; Lillie, JW; O'Keefe, M; Valinski, H; Varban, ML | 1 |
1 other study(ies) available for phosphocyclocreatine and Neoplasms
Article | Year |
---|---|
Cyclocreatine (1-carboxymethyl-2-iminoimidazolidine) inhibits growth of a broad spectrum of cancer cells derived from solid tumors.
Topics: Animals; Antineoplastic Agents; Cell Division; Cell Line; Cell Transformation, Neoplastic; Creatine Kinase; Creatinine; Female; Humans; Imidazolidines; Isoenzymes; Male; Mice; Mice, Nude; Neoplasms; Neoplasms, Experimental; Phosphocreatine; Transplantation, Heterologous; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 1993 |